Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

GeneDx Holdings (WGS) Return on Invested Capital (2022 - 2025)

GeneDx Holdings (WGS) has disclosed Return on Invested Capital for 4 consecutive years, with 0.04% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Invested Capital rose 5.0% to 0.04% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.04%, a 5.0% increase, with the full-year FY2025 number at 0.05%, up 5.0% from a year prior.
  • Return on Invested Capital was 0.04% for Q4 2025 at GeneDx Holdings, down from 0.02% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.02% in Q3 2025 to a low of 1.97% in Q1 2023.
  • A 4-year average of 0.68% and a median of 0.53% in 2024 define the central range for Return on Invested Capital.
  • Peak YoY movement for Return on Invested Capital: tumbled -106bps in 2023, then skyrocketed 148bps in 2024.
  • GeneDx Holdings' Return on Invested Capital stood at 1.47% in 2022, then surged by 51bps to 0.73% in 2023, then soared by 88bps to 0.09% in 2024, then surged by 56bps to 0.04% in 2025.
  • Per Business Quant, the three most recent readings for WGS's Return on Invested Capital are 0.04% (Q4 2025), 0.02% (Q3 2025), and 0.02% (Q2 2025).